Pasithea Therapeutics Cor... (KTTA)

AI Score

Unlock

1.38

0.01 (0.73%)

At close: Apr 17, 2025, 3:59 PM

1.37

-0.75%

After-hours: Apr 17, 2025, 07:18 PM EDT

Pasithea Therapeutics Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q2 2021	Q1 2021	Q4 2020
Period Ending	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020
Cash & Equivalents	6.92M	9.36M	7.97M	12.01M	16.33M	19.58M	26.65M	29.91M	33.15M	42.4M	47.94M	50.32M	52.97M	20.57M	568.98K	1.07M	243.65K
Short-Term Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Long-Term Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Long-Term Assets	n/a	n/a	n/a	n/a	n/a	n/a	-10.11M	619.29K	-11.1M	n/a	-4.41M	n/a	n/a	n/a	n/a	n/a	n/a
Receivables	n/a	n/a	n/a	n/a	40.5K	n/a	n/a	15.78K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Inventory	n/a	n/a	n/a	-40.5K	-40.5K	985.07K	814.57K	920.48K	1.00	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Current Assets	142.94K	98.33K	104.65K	145.15K	145.21K	201.51K	574.7K	347.69K	426.45K	865.99K	79.59K	n/a	n/a	n/a	282.86K	n/a	-0.00
Total Current Assets	7.37M	9.78M	8.64M	13.19M	16.69M	20.77M	28.04M	31.11M	34.08M	44.47M	48.61M	50.95M	53.3M	21.03M	924.76K	1.14M	247.96K
Property-Plant & Equipment	122.34K	127.06K	131.78K	168.52K	220.48K	524.38K	593.18K	635.45K	1.25M	1.27M	579.95K	128.62K	20.12K	8.57K	n/a	n/a	n/a
Goodwill & Intangibles	8.57M	8.73M	8.89M	9.05M	9.2M	9.36M	9.52M	9.68M	9.85M	3.87M	3.83M	n/a	n/a	n/a	n/a	n/a	n/a
Total Long-Term Assets	8.7M	8.86M	9.02M	9.22M	9.42M	9.89M	10.11M	10.93M	11.1M	5.14M	4.41M	128.62K	20.12K	8.57K	n/a	n/a	n/a
Total Assets	16.06M	18.64M	17.66M	22.41M	26.12M	30.66M	38.15M	42.04M	45.18M	49.61M	53.03M	51.08M	53.32M	21.04M	924.76K	1.14M	247.96K
Account Payables	n/a	n/a	1.39M	2.43M	2.55M	1.87M	1.93M	1.45M	1.48M	1.26M	848.69K	n/a	n/a	n/a	n/a	n/a	6.6K
Deferred Revenue	n/a	n/a	n/a	-2.43M	-2.55M	-1.87M	-1.93M	-1.45M	-1.61M	-258.03K	-848.69K	n/a	n/a	n/a	n/a	n/a	n/a
Short-Term Debt	n/a	n/a	n/a	n/a	n/a	n/a	133.34K	264.1K	n/a	258.03K	101.42K	n/a	n/a	n/a	n/a	n/a	n/a
Other Current Liabilities	1.12M	n/a	n/a	n/a	n/a	n/a	n/a	245.54K	235.88K	-258.03K	-101.42K	433.68K	447.28K	528.1K	454.68K	n/a	n/a
Total Current Liabilities	1.12M	660.4K	1.39M	2.47M	2.63M	2.04M	2.23M	2.12M	1.88M	1.51M	950.11K	433.68K	447.28K	528.1K	454.68K	239.45K	6.6K
Long-Term Debt	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Long-Term Liabilities	162.17K	163.58K	93.27K	57.65K	84.36K	29.06K	74.06K	487.15K	460.19K	581.12K	245.8K	667.5K	1.45M	4.04M	n/a	n/a	0.00
Total Long-Term Liabilities	162.17K	163.58K	93.27K	57.65K	84.36K	239.88K	330.14K	787.63K	804.21K	1.31M	604.05K	667.5K	1.45M	4.04M	n/a	n/a	0.00
Total Liabilities	1.28M	823.98K	1.49M	2.52M	2.72M	2.28M	2.56M	2.91M	2.68M	2.82M	1.55M	1.1M	1.9M	4.57M	454.68K	239.45K	6.6K
Total Debt	n/a	n/a	n/a	32.99K	81.68K	385.29K	559.1K	729.56K	926.89K	982.42K	459.66K	n/a	n/a	n/a	n/a	n/a	n/a
Common Stock	139.00	104K	104.00	104.00	104.00	17.47K	18K	18K	17.99K	18.04K	18.05K	17.68K	17.68K	16.7K	16.21K	16.21K	14.94K
Retained Earnings	-49.58M	-46.41M	-43.05M	-39.18M	-35.32M	-30.27M	-26.66M	-22.89M	-19.36M	-11.03M	-6.45M	-3.79M	-2.21M	-2.84M	-1.32M	-590.59K	-40.98K
Comprehensive Income	-7.17K	-35.32K	-8.18K	-5.27K	-4.65K	-7.72K	-3.46K	-3.14K	-661	-146.57K	-64.06K	-15.07K	-10.56K	-3.76K	-2.31K	n/a	-0.00
Shareholders Equity	14.78M	17.81M	16.18M	19.88M	23.4M	28.37M	35.59M	39.14M	42.5M	46.79M	51.47M	49.98M	51.42M	16.48M	470.08K	900.67K	241.35K
Total Investments	n/a	9.35B	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a